MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the third quarter ended September 30, 2015.
Recent Highlights
• Achieved third quarter revenue of $14.2 million, an increase of 56% over the third quarter 2014.
Help employers find you! Check out all the jobs and post your resume.
